$0.79
Hepion Pharmaceuticals is a biotechnology business based in the US. Hepion Pharmaceuticals shares (HEPA) are listed on the NASDAQ and all prices are listed in US Dollars. Hepion Pharmaceuticals employs 22 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Hepion Pharmaceuticals stock
How to buy Hepion Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – HEPA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Hepion Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Hepion Pharmaceuticals stock price (NASDAQ: HEPA)
Use our graph to track the performance of HEPA stocks over time.Hepion Pharmaceuticals shares at a glance
Latest market close | $0.84 |
---|---|
52-week range | $0.90 - $8.92 |
50-day moving average | $1.12 |
200-day moving average | $2.41 |
Wall St. target price | $30.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-9.40 |
Is it a good time to buy Hepion Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hepion Pharmaceuticals price performance over time
Historical closes compared with the close of $0.84 from 2024-07-22
1 week (2024-07-17) | -20.75% |
---|---|
1 month (2024-06-24) | -21.50% |
3 months (2024-04-24) | -36.36% |
6 months (2024-01-24) | -57.79% |
1 year (2023-07-24) | -89.39% |
---|---|
2 years (2022-07-22) | 39.37% |
3 years (2021-07-23) | 1.59 |
5 years (2019-07-24) | 3.03 |
Hepion Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -71.07% |
Return on equity TTM | -172.45% |
Profit margin | 0% |
Book value | $1.07 |
Market Capitalization | $5.9 million |
TTM: trailing 12 months
Hepion Pharmaceuticals share dividends
We're not expecting Hepion Pharmaceuticals to pay a dividend over the next 12 months.
Have Hepion Pharmaceuticals's shares ever split?
Hepion Pharmaceuticals's shares were split on a 1:20 basis on 10 May 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hepion Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Hepion Pharmaceuticals shares which in turn could have impacted Hepion Pharmaceuticals's share price.
Hepion Pharmaceuticals share price volatility
Over the last 12 months, Hepion Pharmaceuticals's shares have ranged in value from as little as $0.9 up to $8.92. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hepion Pharmaceuticals's is 1.857. This would suggest that Hepion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Hepion Pharmaceuticals overview
Hepion Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc.
Frequently asked questions
nullWhat percentage of Hepion Pharmaceuticals is owned by insiders or institutions?
Currently 0.102% of Hepion Pharmaceuticals shares are held by insiders and 12.284% by institutions. How many people work for Hepion Pharmaceuticals?
Latest data suggests 22 work at Hepion Pharmaceuticals. When does the fiscal year end for Hepion Pharmaceuticals?
Hepion Pharmaceuticals's fiscal year ends in December. Where is Hepion Pharmaceuticals based?
Hepion Pharmaceuticals's address is: 399 Thornall Street, Edison, NJ, United States, 08837 What is Hepion Pharmaceuticals's ISIN number?
Hepion Pharmaceuticals's international securities identification number is: US4268971045 What is Hepion Pharmaceuticals's CUSIP number?
Hepion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 21234W400
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question